This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: are often identified after developing anti-Ku, an antibody associated with hemolytic transfusion reactions (HTR) and hemolytic disease of the fetus and newborn (HDFN). Transfusion management in this population is particularly challenging as compatible blood is difficult to find. It is crucial to adopt safe and reliable treatments for preoperative blood management. STUDY DESIGN AND METHODS: woman with potent Ku alloantibody preparing for surgery. Kell antigen typing and titers of anti-Ku were detected by standard serologic techniques. Polymerase chain reaction (PCR) and DNA sequencing of the KEL coding region were performed on her genomic DNA. Therapeutic plasma exchange (TPE) was initiated for five sessions to reduce the high anti-Ku titers before surgery. RESULTS: The red blood cells (RBCs) phenotype of the Kell blood group was identified as K- k-; Kp(a- b-). DNA sequence analysis revealed the patient was homozygous for a nucleotide deletion, NM_000420.3:c.855delT (p.L286*) in exon 8 of the KEL gene. After TPE, the anti-Ku titers decreased from 1:1600 to 1:400. A rebound phenomenon was noted during the procedures. DISCUSSION: phenotype in a Chinese woman with Ku alloimmunization. TPE proved to be effective for decreasing anti-Ku titers. However, the rebound of antibodies should be considered when using TPE to decrease the antibody titers. This report demonstrates a new attempt in preoperative transfusion management for patients with rare alloantibodies.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Du et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: